1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6AE68AD8C9E79BDF565258384001C24EE
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/competitive-intelligence-landscape-assessment-communication-channels-insight-types-hallmarks-excellence?opendocument
18
19opendocument
2034.229.76.193
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Competitive and Business Intelligence Strategic Insights

Competitive Intelligence Landscape Assessment: Communication Channels, Insight Types and Hallmarks of Excellence

ID: 5545


Features:

17 Info Graphics

13 Data Graphics

190+ Metrics


Pages/Slides: 37


Published: 2019


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Competitive Intelligence Landscape Assessment: Communication Channels, Insight Types and Hallmarks of Excellence”

STUDY OVERVIEW

In the constantly evolving and complex biopharma marketplace, Competitive Intelligence groups play a significant role in corporate success by delivering actionable insights that help set a company's strategic direction. The effectiveness of Competitive Intelligence groups, in turn, is largely predicated on the type of insights the group generates and how well those insights are communicated to inform leadership and decision making.

Best Practices, LLC conducted this landscape assessment using a meta-analysis approach to identify evolutionary insights for Competitive Intelligence communication channels, insight types and hallmarks of excellence in the biopharmaceutical industry. Insights in this research have been distilled from 10 of Best Practices, LLC’s existing benchmarking studies on the CI function.

KEY TOPICS

  • Competitive intelligence communication channels and frequencies to inform leadership and decision making
  • Most valued types of competitive intelligence insight
  • Case studies to show management how best-in-class competitive intelligence functions contribute and add value
  • Hallmarks of high performing competitive intelligence professionals and organizations

KEY METRICS
  • Which departments generate the maximum number of competitive intelligence project requests?
  • On average, how many total competitive intelligence service requests do you get in a month?
  • Top delivery formats for competitive intelligence insights
  • How effective are each of the listed communication and delivery channels for conveying a competitive landscape assessment?
  • How often do you present updated competitive landscape assessments to senior leadership?
  • How important is each general product or therapeutic area component as part of a 1-page competitive landscape template to help a senior leader understand critical dynamics of the market environment?
  • How many pages or slides are contained on average in each high-level template or executive brief when presenting competitive assessments to each leadership group?

SAMPLE KEY FINDINGS
  • Top Delivery Formats for Competitive Intelligence Insights: Ad-hoc reports, early warning alerts, and scheduled competitive intelligence reports are the most impactful formats for informing key leaders.
  • Best Channels for Communicating Landscapes & Key Intelligence: Executive meetings and one-on-one personal meetings are the most effective channels for delivering critical intelligence to senior leadership.

METHODOLOGY

Best Practices, LLC captured data from 10 of its benchmarking studies to conduct a Competitive Intelligence Landscape Assessment for the biopharmaceutical sector.


Industries Profiled:
Medical Device; Pharmaceutical; Health Care; Diagnostic; Manufacturing; Biotech; Biopharmaceutical; Technology; Communications; Consumer Products; Banking; Financial Services; Insurance; Research; Marketing; Chemical; High Tech; Consulting; Service; Electronics; Internet; Distribution; Computer Software; Energy; Clinical Research; Laboratories; Computers; Utilities; Telecommunications; Engineering; Shipping; Professional Services; Logistics; Science


Companies Profiled:
3M Pharmaceuticals; Abbott; Abbott Nutrition; Abbott Laboratories; AbbVie; actavis; Aditya Birla Group; Adocia; Alcon; Alcon Laboratories; Alembic; Alkermes; Allergan; Alnylam Pharmaceuticals; Amgen; Amylin; Anoto; ApotheCom; ARIAD; Array BioPharma; Astellas; AstraZeneca; B.Braun; Bausch & Lomb; Baxter Healthcare; Baxter International; Bayer Healthcare; Bayer; Biocon; BioCryst Pharmaceuticals; Biogen; Biogen Idec; Biological E. Limited; BioMarin; Biovail; Bioventus; Boehringer Ingelheim; Bristol-Myers Squibb; Cadila Pharmaceuticals; Centocor; Inc.; Central Bank of India; Citibank; Colorcon; ConjuChem Biotechnologies; Covance; Covidien; CSL Behring; Cubist Pharmaceuticals; Daiichi Sankyo; Datamatics Financial Services; Dendreon Corporation; Dentsply International; Diners Club International; doTerra; Dr Reddy's Laboratories; Eisai; Eli Lilly and Company; EMD Serono; Emergent BioSolutions; Endo Pharmaceuticals; Essilor International S.A.; Ethicon Endo-Surgery Inc.; Ethicon; Johnson & Johnson; Ethos Health Communications; Farma Health; Ferring Pharmaceuticals; Genentech; GlaxoSmithKline ; Gilead Sciences; Glenmark; Grifols; Human Genome Sciences; IBM; Immunex; IMS Health; Indegene Lifesystems; Infosys; Inspire Pharmaceuticals; Intel; Intermountain Healthcare; Ipsen; Ironwood; Janssen; Jazz Pharmaceuticals; King Pharmaceuticals; Kodak; Lac Mac; Lilly; Lonza Inc.; Mallinckrodt; McKesson; MedImmune; Medtronic; Medrad; Merck; Merck Serono; MyDataBall; Novartis; Nova Nordisk; Oracle; Orion Pharmaceuticals; PDL; PDL BioPharma; Pfizer; Pharma Consulting; Phillips; Procter & Gamble Pharma; Progress Energy; ProStrakan; Purdue Pharma; Quintiles; Ranbaxy; Roche; Rxperts; Salt Creek Biosciences; Sanofi; Sanofi Pasteur; Sanofi-Aventis; Santen; SAS; Sequor; Shire; Stiefel; Sunovion; Syntel; Takeda Pharmaceuticals; Tata Technologies; Teleflex; Tesaro; Teva Pharmaceutical Industries Ltd; Theratechnologies; Torrent Pharmaceuticals Ltd.; Transform Strategy Partners; UCB Pharma; UPS; Upsher-Smith; Vertex Pharmaceuticals; Vifor Pharma; Vivus; VMware; Waters; Waters Corporation; Women's Choice Pharmaceuticals; Wyeth Nutrition/Nestle; Xanodyne Pharmaceuticals; Zydus


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.